Oncotelic Therapeutics (OTLC) Restructuring Costs (2011 - 2012)
Oncotelic Therapeutics (OTLC) posted Restructuring Costs of $15,000 for FY2012, down 98.7% from $1.15 million in FY2011.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Restructuring Costs (2011 - 2012) Analysis & Trends
- Business Quant data shows OTLC's Restructuring Costs at $1.15 million in FY2011 (+124.7%) and $510,000 in FY2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2012 | 4,000.00 |
| Jun 30, 2012 | -2,000.00 |
| Mar 31, 2012 | 13,000.00 |
| Sep 30, 2011 | 1.15 Mn |
API Access
Oncotelic Therapeutics Restructuring Costs API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=restructuring-costs&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "restructuring-costs", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=restructuring-costs&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();